PJC
BSX icon

Phillip James Consulting’s Boston Scientific BSX Stock Holding History

Phillip James Consulting’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$150K Hold
3,520
– – 0.1% 59
2026
Q1 		$220K Buy
+3,520
New +$282K 0.17% 63

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Phillip James Consulting's BSX Position: Q2 2026 in Review

Phillip James Consulting held its Boston Scientific (BSX) position steady in Q2 2026 at 3,520 shares worth $150K. The position accounts for 0.1% of the portfolio, ranked #59.

Phillip James Consulting first reported a position in BSX in Q1 2026 and has held it in 2 quarters since. The position peaked at $220K in Q1 2026. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Phillip James Consulting held 3,520 shares of Boston Scientific worth $150K as of Q2 2026.
  • Phillip James Consulting left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up 0.1% of Phillip James Consulting's portfolio in Q2 2026, its #59 holding.
  • Phillip James Consulting first reported a position in Boston Scientific in Q1 2026 and has held it in 2 quarters since.
  • Phillip James Consulting's Boston Scientific position peaked at $220K in Q1 2026.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Phillip James Consulting's 13F filing for Q2 2026, filed 28 Jul 2026.